Twin Tree Management »

Blueprint Medicines shares owned by Twin Tree Management

Quarter-by-quarter ownership of Blueprint Medicines (BPMC) shares owned by Twin Tree Management from 13F filings

Historical chart of Twin Tree Management investment in Blueprint Medicines

Tip: Access up to 7 years of quarterly data

All positions including Blueprint Medicines held by Twin Tree Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Blueprint Medicines by Twin Tree Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $21M 195k 107.78
2024-03-31 $6.6M 70k 94.86
2023-12-31 $421k 4.6k 92.24
2021-09-30 $150k 1.5k 102.74

More positions owned by Twin Tree Management

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Spdr Gold Tr Gold Shs Call Option (GLD)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Ishares Gold Tr Ishares New Call Option (IAU)
Apple Call Option (AAPL)
United Parcel Service CL B Call Option (UPS)
Servicenow Call Option (NOW)
Broadcom Call Option (AVGO)
Ishares Silver Tr Ishares Call Option (SLV)
Microsoft Corporation Call Option (MSFT)
Intuit Call Option (INTU)
Adobe Systems Incorporated Call Option (ADBE)
TJX Companies Call Option (TJX)
Palo Alto Networks Put Option (PANW)
Amgen Call Option (AMGN)

View all positions for Twin Tree Management

Top funds holding Blueprint Medicines

BlackRock
BlackRock
Vanguard Group
T. Rowe Price Associates
Rock Springs Capital Management
State Street Corporation
Jane Street
William Blair Investment Management
Geode Capital Management
Macquarie Group
Jpmorgan Chase & Co
Lord, Abbett & Co
Pictet Asset Management Holding SA
Alliancebernstein
Invesco

View all funds holding Blueprint Medicines